Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use
Clinical trial NCT02959983 · COMPLETED
Trial details
- NCT number
- NCT02959983
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-25
- Primary completion
- 2018-01-22
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.